Form 4 Tracker
Passage BIO, Inc.
PASG

2 insider filings · Latest: Mar 16, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jan 9, 2026Jan 9 9:03 PMChou William
Proposed Sale
4,076$18.43$75.1K

View →

Jul 21, 2025Jul 21 9:33 PMOrbiMed Private Investments VII, LP
Proposed Sale
132,645$5.56$737.5K

View →

Jul 15, 2025Jul 16 12:17 AMOrbiMed Private Investments VII, LP
Proposed Sale
53,293$6.79$361.9K

View →

Jul 7, 2025Jul 7 10:02 PMOrbiMed Private Investments VII, LP
Proposed Sale
259,000$0.433$112.1K

View →

Jun 24, 2025Jun 24 10:48 PMOrbiMed Private Investments VII, LP
Proposed Sale
1,076,120$0.3516$378.4K

View →

Apr 15, 2025Apr 15 9:40 PMOrbiMed Private Investments VII, LP
Proposed Sale
787,179$0.383$301.5K

View →

Jan 6, 2025Jan 6 9:57 PMOrbiMed Private Investments VII, LP
Proposed Sale
1,140,740$0.829$945.7K

View →

Dec 4, 2024Dec 5 12:03 AMOrbiMed Private Investments VII, LP
Proposed Sale
2,985,518$0.89$2.7M

View →

Dec 4, 2024Dec 4 11:57 PMWorldwide Healthcare Trust PLC
Proposed Sale
2,028,307$0.89$1.8M

View →

Sep 16, 2024Sep 17 12:38 AMWorldwide Healthcare Trust PLC
Proposed Sale
241,328$0.807$194.8K

View →

Sep 16, 2024Sep 17 12:36 AMOrbiMed Private Investments VII, LP
Proposed Sale
927,572$0.807$748.6K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Mar 16, 2026Mar 18 8:07 PMKathleen BorthwickCFO
Grant/Award
15,610$7.6415,610(D)

View →

Mar 16, 2026Mar 18 8:06 PMWilliam ChouDirector, PRESIDENT AND CEO
Grant/Award
58,000$7.6458,000(D)

View →